Nomura Maintains Neutral Ratings on Apollo Hospitals and Fortis
Nomura estimates the government's 30% cap on trade margins for non-scheduled anti-cancer drugs could have a mid-to-high single-digit impact on EBITDA at its covered hospitals.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.